# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number:

k182123

# B. Purpose for Submission:

Modification of a previously cleared device (k122809) to add Amphetamine $\mathrm { ( 1 0 0 0 n g / m L }$ cutoff), Methamphetamine $\mathrm { \Omega ( 1 0 0 0 ~ n g / m L }$ cutoff), Cocaine $( 3 0 0 ~ \mathrm { n g / m L }$ cutoff), and 6- Acetylmorphine devices ( $1 0 ~ \mathrm { n g / m L }$ cutoff), and to change the formulation of the previously cleared Morphine device.

# C. Measurands:

Amphetamine, Methamphetamine, Cocaine, Morphine, and 6-Acetylmorphine

# D. Type of Test:

Qualitative, lateral flow immunoassay

# E. Applicant:

Advin Biotech, Inc.

F. Proprietary and Established Names:

ATTEST Drug Screen Cup ATTEST Drug Screen Dip Card

# G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Regulation names</td><td rowspan=1 colspan=1>ProductCode</td><td rowspan=1 colspan=1>Class</td><td rowspan=1 colspan=1>Regulation</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>Opiate Test System</td><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>862.3650</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>Amphetamine Test system</td><td rowspan=1 colspan=1>DKZ</td><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>862.3100</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>Cocaine and metabolites Test System</td><td rowspan=1 colspan=1>DIO</td><td rowspan=1 colspan=1>Ⅱ</td><td rowspan=1 colspan=1>862.3250</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine Test System</td><td rowspan=1 colspan=1>DJC</td><td rowspan=1 colspan=1>Ⅱ</td><td rowspan=1 colspan=1>862.3610</td><td rowspan=1 colspan=1>Toxicology (91)</td></tr></table>

# H. Intended Use:

1. Intended use(s): Refer to Indications for Use

2. Indication(s) for use:

The ATTEST Drug Screen Cup and the ATTEST Drug Screen Dip Card are rapid lateral flow immunoassays for the qualitative detection of 6-Acetylmorphine, d-Amphetamine, Benzoylecgonine, Buprenorphine, EDDP, $\mathrm { d } / 1$ -Methadone, d-Methamphetamine, $\mathrm { d } / 1$ - Methylenedioxymethamphetamine, Morphine, Nortriptyline, Oxazepam, Oxycodone, Phencyclidine, d-Propoxyphene, Secobarbital and THC-COOH in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows:

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Cutoff (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>6-Acetylmorphine</td><td rowspan=1 colspan=1>6-monoacetylmorphine</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>d-Amphetamine</td><td rowspan=1 colspan=1>500</td></tr><tr><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>d-Amphetamine</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>Barbiturates</td><td rowspan=1 colspan=1>Secobarbital/Pentobarbital</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Benzodiazepines</td><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>2-ethylidene-1,5-dimethyl-3-3-diphenylpyrrolidine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>150</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Ecstasy</td><td rowspan=1 colspan=1>d,1-Methylenedioxymethamphetamine</td><td rowspan=1 colspan=1>500</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>d-Methamphetamine</td><td rowspan=1 colspan=1>500</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>d-Methamphetamine</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>Marijuana</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td><td rowspan=1 colspan=1>50</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>d/1-Methadone</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Opiates</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Opiates</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Propoxyphene</td><td rowspan=1 colspan=1>Propoxyphene</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>TricyclicAntidepressants</td><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>1,000</td></tr></table>

The single or multi-test panels can consist of the above listed analytes in any combination, up to a maximum of 16 analytes, with and without on-board

adulteration/specimen validity tests (SVT) in the dip card format and in the cup format.   
The drug screen tests are intended for prescription use only.

The tests provide only a preliminary result. A more specific alternative chemical method should be used in order to obtain a confirmed presumptive positive result if the donor doesn’t admit use or anytime required by testing procedures. Gas Chromatography / Mass Spectrometry (GC/MS), Liquid Chromatography / Mass Spectrometry (LC/MS) and their tandem mass-spectrometer versions are the preferred confirmatory methods. Careful consideration and judgment should be applied to any drugs of abuse screen test result, particularly when evaluating preliminary positive results.

3. Special conditions for use statement(s): This assay is intended for prescription use

4. Special instrument requirements: Not applicable.

# I. Device Description:

The ATTEST Drug Screen Cup and ATTEST Drug Screen Dip Card devices are immunochromatographic assays that use a lateral flow system for the qualitative detection of Amphetamine, Methamphetamine, Barbiturates, Benzodiazepine, Cannabinoids, Cocaine, Methadone, Tricyclic antidepressants, Buprenorphine, EDDP, MDMA, Morphine, Oxycodone, Phencyclidine, Propoxyphene, and 6-Acetylmorphine. The ATTEST Drug Screen Cup device consists of a cup device and a package insert. The ATTEST Drug Screen Dip Card device consists of a Dip Card device, a package insert and a urine cup for sample collection.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Advin Multi-Drug Screen Test Cup, Advin Multi-Drug Screen Test Dipcard

2. Predicate 510(k) number(s): k122809

Predicate Similarities and Differences Table for All Assays   

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Candidate Devic</td><td rowspan=1 colspan=1>Predicate Device (k122809)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Qualitative detection of drugsof abuse and/or theirmetabolites in urine</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Lateral flowimmunochromatographicassay based on competitivebinding</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Urine</td></tr><tr><td rowspan=1 colspan=1>Analyte cutoffs(ng/mL)</td><td rowspan=1 colspan=1>Same except for thefollowing analytes:6-AM - 10Amphetamine - 1,000Cocaine - 300Methamphetamine - 1,000Opiates - 300</td><td rowspan=1 colspan=1>Amphetamine - 500Barbiturates - 300Benzodiazepine - 300Buprenorphine - 10Cocaine - 150EDDP - 300Ecstasy - 500Methamphetamine - 500Methadone - 300Morphine - 300Opiates - 2,000Oxycodone - 100Phencyclidine - 25Propoxyphene - 300Tricyclics - 1,000Marijuana - 50</td></tr><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Formats</td><td rowspan=1 colspan=1>Cup and Dip Card only</td><td rowspan=1 colspan=1>Cup, Dip Card, Cassette</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

None referenced

# L. Test Principle:

Each device employs lateral flow immunochromatographic technology and is based on the principle of competitive binding. Drugs, if present in concentrations below the cutoff level, will not saturate the binding sites of the antibody coated particles on the drug specific test strips. The goat-anti-rabbit IgG antibody-coated particles will then be captured by immobilized drug-specific conjugate. If the level of drug in the urine specimen is below the cutoff concentration, the T line appears as a visible burgundy line. If the level of drug in the urine specimen is above the cutoff, no T line develops.

The control line (C line) serves as an internal quality control. The control line should always appear as a burgundy-colored band regardless of the presence of the drug, if enough sample volume has been added to the test and if the sample has correctly migrated up the test strip. Testing is based on the principle of a competitive immunochemical reaction between a chemically labeled drug (drug-protein conjugate) and the drug or drug metabolites which may be present in the urine sample competing for the limited antibody binding sites.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

# a. Precision/Reproducibility:

The precision study of the ATTEST Drug Screen Cup and Dip card were evaluated for Amphetamine ( $\mathrm { 1 0 0 0 n g / m L }$ cutoff, AMP 1000), Methamphetamine $( 1 0 0 0 ~ \mathrm { n g / m L }$ cutoff, MET 1000), Cocaine $( 3 0 0 ~ \mathrm { n g / m L }$ cutoff, COC 300), Opiates $( 3 0 0 ~ \mathrm { n g / m L }$ cutoff, OPI 300) and 6-Acetylmorphine devices ( $1 0 ~ \mathrm { n g / m L }$ cutoff, 6-AM 10) at three external testing sites. Samples tested were drug free urine spiked with certified reference standards to the target concentrations. The test solutions contain the following drug concentrations: negative, $+ / - 7 5 \%$ cutoff, $+ / - 5 0 \%$ cutoff, $+ / - 2 5 \%$ cutoff, and $+ 1 0 0 \%$ cutoff. All test solutions were confirmed by a chemically specific quantitative method to verify the drug concentrations.

Three operators performed the study using three lots of ATTEST Cup Drug Screen and three lots of ATTEST Card Drug Screen. Each sample was tested in 20 replicates for each device format at each of three sites. A total of 180 specimens for each device format were tested over 10 non-consecutive days. The results are shown in the tables below. Performance data for Amphetamine $\mathrm { 5 0 0 \ n g / m L }$ cutoff), Barbiturates, Benzodiazepines, Buprenorphine, EDDP, Cocaine ( $1 5 0 ~ \mathrm { n g / m L }$ cutoff), Ecstasy, Methamphetamine $( 5 0 0 ~ \mathrm { n g / m L }$ cutoff), Marijuana, Methadone, Opiates $( 2 0 0 0 ~ \mathrm { n g / m L }$ cutoff), Oxycodone, Phencyclidine, Propoxyphene, and Tricyclic Antidepressants was provided in k122809.

Precision Study Result of ATTEST Cup:

<table><tr><td rowspan=1 colspan=1>Drug Test</td><td rowspan=1 colspan=1>Results</td><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>+100%Cutoff</td></tr><tr><td rowspan=3 colspan=1>6-AM 10</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>97%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=3 colspan=1>AMP1000</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>55</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>97%</td><td rowspan=1 colspan=1>••</td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr></table>

Precision Study Result of ATTEST Dip Card:   

<table><tr><td rowspan=3 colspan=1>COC 300</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1>---</td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>MET 1000</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>57</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>97%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>95%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=3 colspan=1>OPI 300</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>93%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>93%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>DrugTest</td><td rowspan=1 colspan=1>Results</td><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>+100%Cutoff</td></tr><tr><td rowspan=3 colspan=1>6-AM 10</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=3 colspan=1>AMP 1000</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>_-----</td><td rowspan=1 colspan=1>97%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=3 colspan=1>COC 300</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>57</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>95%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=3 colspan=1>MET 1000</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>31</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1>-----</td><td rowspan=1 colspan=1>97%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=3 colspan=1>OPI 300</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>98%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr></table>

# $b$ . Linearity/assay reportable range:

Not applicable.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

This device has internal process controls. A colored line appearing in the control region confirms sufficient sample volume and adequate membrane wicking. Users are informed that the test is invalid if a line fails to appear in the control region. There are no external controls supplied with the device.

Device stability has been evaluated through accelerated and real-time studies. Protocols and acceptance criteria were described and found to be acceptable. The manufacturer claims that the devices are stable for 28 months.

d. Detection limit:

Not applicable.

e. Analytical specificity:

Analytical specificity for both the ATTEST Drug Screen Cup and the ATTEST Drug Screen Dip Card was determined through the testing of contrived solutions made by spiking certified standards of chemically-related or structurally-similar compounds into drug free urine. The relative cross-reactivity represents the minimum concentration necessary to yield a result similar to the cutoff level of the respective assay. Identical results, provided in the table below, were obtained with the two devices. Performance data for Amphetamine $\mathrm { \Delta 5 0 0 ~ n g / m L }$ cutoff), Barbiturates, Benzodiazepines, Buprenorphine, EDDP, Cocaine ( $1 5 0 ~ \mathrm { n g / m L }$ cutoff), Ecstasy, Methamphetamine ( $\mathrm { 5 0 0 \ n g / m L }$ cutoff), Marijuana, Methadone, Opiates $\mathrm { \Omega } 2 0 0 0 \mathrm { n g / m L }$ cutoff), Oxycodone, Phencyclidine, Propoxyphene, and Tricyclic Antidepressants was provided in k122809.

<table><tr><td colspan="1" rowspan="1">Assay/Cutoff</td><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">Relative cross-reactivity (%)</td></tr><tr><td colspan="1" rowspan="6">6-AM 10</td><td colspan="1" rowspan="1">6-acetylmorphine</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine(heroin)</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">3.3</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.1</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.1</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.1</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.1</td></tr><tr><td colspan="1" rowspan="4">AMP 1000</td><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">MDA</td><td colspan="1" rowspan="1">15,000</td><td colspan="1" rowspan="1">6.7</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">1.0</td></tr><tr><td colspan="1" rowspan="3">COC 300</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Cocaethylene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Assay/Cutoff Compound</td><td colspan="1" rowspan="1">Assay/Cutoff Compound</td><td colspan="1" rowspan="1">Concentration(ng/mL)</td><td colspan="1" rowspan="1">Relative cross-reactivity (%)</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Ecgonine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="8">MET 1000</td><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">30,000</td><td colspan="1" rowspan="1">3.3</td></tr><tr><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">1R, 2S(1)-Ephedrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">MDEA</td><td colspan="1" rowspan="1">60,000</td><td colspan="1" rowspan="1">1.7</td></tr><tr><td colspan="1" rowspan="1">MDMA</td><td colspan="1" rowspan="1">8,000</td><td colspan="1" rowspan="1">12.5</td></tr><tr><td colspan="1" rowspan="1">Mephentermine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="13">OPI 300</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">6-Acetylmorphine (6-AM)</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">300</td></tr><tr><td colspan="1" rowspan="1">Codeine-6-β-glucuronide</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine (heroin)</td><td colspan="1" rowspan="1">900</td><td colspan="1" rowspan="1">33.3</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Morphine-3-glucuronide</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">30,000</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">70,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">Thebaine</td><td colspan="1" rowspan="1">20,000</td><td colspan="1" rowspan="1">1.5</td></tr></table>

The potential interference from compounds chemically dissimilar to target drugs, and known endogenous agents was also determined for both the ATTEST Drug Screen Cup and the ATTEST Drug Screen Dip Card. Testing of compounds and endogenous agents was performed by spiking the substances noted in the table below into pooled urine containing target drugs at near-cutoff concentrations. Identical results, provided in the table below, were obtained with the two devices. Unless otherwise indicated, substances were tested for potential interference at a concentration of $1 0 0 ~ \mu \mathrm { g / m L }$ . Performance data for Amphetamine $( 5 0 0 ~ \mathrm { n g / m L }$ cutoff), Barbiturates, Benzodiazepines, Buprenorphine, EDDP, Cocaine ( $1 5 0 ~ \mathrm { n g / m L }$ cutoff), Ecstasy, Methamphetamine ( $\mathrm { 5 0 0 \ n g / m L }$ cutoff), Marijuana, Methadone, Opiates $( 2 0 0 0 ~ \mathrm { n g / m L }$ cutoff), Oxycodone, Phencyclidine, Propoxyphene, and Tricyclic Antidepressants was provided in k122809.

The following substances demonstrated no interference to the assays encompassed in this submission.   

<table><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">Acetone</td><td colspan="1" rowspan="1">Acetylsalicylic acid</td></tr><tr><td colspan="1" rowspan="1">Albumin</td><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Ascorbic acid</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Benzocaine</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Chloroquine</td></tr><tr><td colspan="1" rowspan="1">Chlorpheniramine</td><td colspan="1" rowspan="1">Creatine</td><td colspan="1" rowspan="1">Dexbrompheniramine</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Dimethylaminoantipyrine</td><td colspan="1" rowspan="1">Diphenhydramine</td></tr><tr><td colspan="1" rowspan="1">Dimenhydrinate</td><td colspan="1" rowspan="1">Dopamine</td><td colspan="1" rowspan="1">Isoproterenol</td></tr><tr><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Ethanol</td></tr><tr><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Gabapentin</td><td colspan="1" rowspan="1">Glucose</td></tr><tr><td colspan="1" rowspan="1">Guaiacol glyceryl ether</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Ibuprofen</td></tr><tr><td colspan="1" rowspan="1">Isoproterenol</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Lidocaine</td></tr><tr><td colspan="1" rowspan="1">Methylephedrine</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Niacinamide</td></tr><tr><td colspan="1" rowspan="1">Nicotine</td><td colspan="1" rowspan="1">Norephedrine</td><td colspan="1" rowspan="1">Oxalic acid</td></tr><tr><td colspan="1" rowspan="1">Pantoprazole</td><td colspan="1" rowspan="1">Penicillin-G</td><td colspan="1" rowspan="1">Pheniramine</td></tr><tr><td colspan="1" rowspan="1">Phenothiazine</td><td colspan="1" rowspan="1">1-Phenylephrine</td><td colspan="1" rowspan="1">B-Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">Pregablin</td><td colspan="1" rowspan="1">Procaine</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Ranitidine</td><td colspan="1" rowspan="1">Riboflavin</td><td colspan="1" rowspan="1">Sertraline</td></tr><tr><td colspan="1" rowspan="1">Sodium chloride</td><td colspan="1" rowspan="1">Sulindac</td><td colspan="1" rowspan="1">Theophylline</td></tr><tr><td colspan="1" rowspan="1">Tyramine</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr></table>

Interference from $\mathsf { p H }$ and specific gravity variation was also evaluated for both the ATTEST Drug Screen Cup and the ATTEST Drug Screen Dip Card using pooled urine specimens containing target drugs at near-cutoff concentrations. The results demonstrated that $\mathsf { p H }$ levels of 4 to 9 and specific gravity levels of 1.003 to 1.030 do not affect the results of the assays for either of the devices. Performance data for Amphetamine $\mathrm { 5 0 0 \ n g / m L }$ cutoff), Barbiturates, Benzodiazepines, Buprenorphine, EDDP, Cocaine ( $1 5 0 ~ \mathrm { n g / m L }$ cutoff), Ecstasy, Methamphetamine $\mathrm { 5 0 0 \ n g / m L }$ cutoff), Marijuana, Methadone, Opiates $\mathrm { \Omega } 2 0 0 0 \mathrm { n g / m L }$ cutoff), Oxycodone, Phencyclidine, Propoxyphene, and Tricyclic Antidepressants was provided in k122809.

f. Assay cut-off:

For characterization of how the device performs analytically around the claimed cutoff concentration, please refer to section M.1.a., above.

2. Comparison studies:

# a. Method comparison with predicate device:

A method comparison study was conducted for the ATTEST Drug Screen Cup and ATTEST Drug Screen Dip card, using clinical urine specimens quantitated for the target drugs of abuse by chemically specific quantitative methods (e.g. LC-MS). Identical results, provided in the table below, were obtained with the two devices. Performance data for Amphetamine $( 5 0 0 ~ \mathrm { n g / m L }$ cutoff), Barbiturates, Benzodiazepines, Buprenorphine, EDDP, Cocaine ( $1 5 0 ~ \mathrm { n g / m L }$ cutoff), Ecstasy, Methamphetamine $\mathrm { 5 0 0 \ n g / m L }$ cutoff), Marijuana, Methadone, Opiates $( 2 0 0 0 ~ \mathrm { n g / m L }$ cutoff), Oxycodone, Phencyclidine, Propoxyphene, and Tricyclic Antidepressants was provided in k122809.

Summary of Discordant Results:   

<table><tr><td rowspan=2 colspan=1>Device</td><td rowspan=2 colspan=1>DeviceResult</td><td rowspan=1 colspan=4>Concentration determined by chemically specificquantitative method (e.g. LC/MS)</td></tr><tr><td rowspan=1 colspan=1>≤50% cutoffconcentration</td><td rowspan=1 colspan=1>Near CutoffNegative (-50% to thecutoffconcentration)</td><td rowspan=1 colspan=1>NearCutoffPositive(cutoff to150% ofthe cutoff)</td><td rowspan=1 colspan=1>High Positive(≥150% ofthe cutoff)</td></tr><tr><td rowspan=2 colspan=1>6-AM/10</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>35</td></tr><tr><td rowspan=2 colspan=1>AMP/1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=2 colspan=1>COC/300</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>35</td></tr><tr><td rowspan=2 colspan=1>MET/1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=2 colspan=1>OPI/300</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>46</td></tr></table>

<table><tr><td rowspan=2 colspan=1>Drug / Cutoff (ng/ml)</td><td rowspan=2 colspan=1>ATTEST Cup Result</td><td rowspan=1 colspan=2>GC/MS result</td></tr><tr><td rowspan=1 colspan=1>Drug Concentration (ng/ml)</td><td rowspan=1 colspan=1>Analyte</td></tr><tr><td rowspan=1 colspan=1>OPI/300</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>289</td><td rowspan=1 colspan=1>Morphine</td></tr></table>

b. Matrix comparison: Not applicable.

3. Clinical studies: a. Clinical Sensitivity: Not applicable. b. Clinical specificity: Not applicable. c. Other clinical supportive data (when a. and b. are not applicable):

4. Clinical cut-off:

Not applicable.

5. Expected values/Reference range: Not applicable.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Parts 801 and 809, as applicable.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.